CSCO 2016:吴一龙教授开幕致辞,让人动容!

2016-09-23 MedSci MedSci原创

2016年9月23日14:15,第19届全国临床肿瘤学大会暨2016年CSCO学术年会在福建厦门国际会议中心隆重开幕。出席此次盛会的有大会的荣誉主席孙燕院士和管忠震教授以及大会主席吴一龙教授,秦叔逵教授,马军教授等,中国临床肿瘤学会秘书长李进教授主持了大会的开幕式。中国临床肿瘤学会名誉主席,中国癌症研究基金会副理事长孙燕院士代表主席团发表讲话,大会主席、理事长吴一龙教授发表致辞。吴一龙教授 广东省



2016年9月23日,第19届全国临床肿瘤学大会暨2016年CSCO学术年会在福建厦门国际会议中心隆重开幕。梅斯医学作为受邀媒体参加了此次盛会,将开幕式的盛况与大家分享。



出席此次盛会的有大会的荣誉主席孙燕院士和管忠震教授以及大会主席吴一龙教授,秦叔逵教授,马军教授等,中国临床肿瘤学会秘书长李进教授主持了大会的开幕式。中国临床肿瘤学会名誉主席,中国癌症研究基金会副理事长孙燕院士代表主席团发表讲话,大会主席、理事长吴一龙教授发表致辞。



吴一龙教授 广东省人民医院 广东省肺癌研究所 CSCO理事长

吴一龙教授慷慨激昂的开幕词,令人动容。

“非常高兴和欢迎来自各国的国际讲者,今天的国际讲者将近200位,还有两万多名会员齐聚厦门,是何等壮观的现象。感谢CSCO 的全部理事和副理事长们,正是你们的努力工作使CSCO得以顺利发展,才使CSCO像历史车轮一样向前发展。感谢会员和媒体朋友们,正是你们的支持,才使得CSCO发展壮大,没有你们,CSCO没有今天,非常感谢大家的热情参与,大家的热情参与正是CSCO前进的动力,希望大家继续给CSCO添砖添瓦。过去的一年里,我们的学术研究走向了新的台阶,在CSCO和ASCO的投稿量仅次于美国居全球第二位。我们看到了我们的成长,我们的力量和我们的未来,今天的一切是我们共同创造的,我们今天共同走过的路就是记忆一段历史,希望明年此时我们蓦然回首,CSCO将更加辉煌。”

同时,此次开幕式上,特设颁奖典礼,从收到的1200多篇投稿中选出了10篇2016年度中国临床肿瘤学科学基金优秀论文。

中国医学科学院肿瘤医院赫捷院士在2016年初发表Cancer statistics in China, 2015(IF:137.578)获得2016年CSCO年度成就奖。

10篇优秀论文,见下图:






 

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=144592, encodeId=299a14459254, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 16:11:20 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144591, encodeId=8d73144591dc, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 16:11:09 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137096, encodeId=303413e096f8, content=动容在哪里呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Wed Sep 28 18:45:23 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135421, encodeId=b87713542195, content=收获很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Mon Sep 26 13:05:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134151, encodeId=b6e7134151f7, content=学习了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 24 08:57:00 CST 2016, time=2016-09-24, status=1, ipAttribution=)]
    2016-10-11 1e0d99ddm02(暂无匿称)

    总结的很好!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=144592, encodeId=299a14459254, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 16:11:20 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144591, encodeId=8d73144591dc, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 16:11:09 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137096, encodeId=303413e096f8, content=动容在哪里呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Wed Sep 28 18:45:23 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135421, encodeId=b87713542195, content=收获很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Mon Sep 26 13:05:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134151, encodeId=b6e7134151f7, content=学习了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 24 08:57:00 CST 2016, time=2016-09-24, status=1, ipAttribution=)]
    2016-10-11 1e0d99ddm02(暂无匿称)

    分享一下!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=144592, encodeId=299a14459254, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 16:11:20 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144591, encodeId=8d73144591dc, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 16:11:09 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137096, encodeId=303413e096f8, content=动容在哪里呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Wed Sep 28 18:45:23 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135421, encodeId=b87713542195, content=收获很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Mon Sep 26 13:05:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134151, encodeId=b6e7134151f7, content=学习了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 24 08:57:00 CST 2016, time=2016-09-24, status=1, ipAttribution=)]
    2016-09-28 oo902

    动容在哪里呢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=144592, encodeId=299a14459254, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 16:11:20 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144591, encodeId=8d73144591dc, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 16:11:09 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137096, encodeId=303413e096f8, content=动容在哪里呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Wed Sep 28 18:45:23 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135421, encodeId=b87713542195, content=收获很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Mon Sep 26 13:05:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134151, encodeId=b6e7134151f7, content=学习了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 24 08:57:00 CST 2016, time=2016-09-24, status=1, ipAttribution=)]
    2016-09-26 1e0bc67dm33(暂无匿称)

    收获很多

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=144592, encodeId=299a14459254, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 16:11:20 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144591, encodeId=8d73144591dc, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 16:11:09 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137096, encodeId=303413e096f8, content=动容在哪里呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Wed Sep 28 18:45:23 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135421, encodeId=b87713542195, content=收获很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Mon Sep 26 13:05:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134151, encodeId=b6e7134151f7, content=学习了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 24 08:57:00 CST 2016, time=2016-09-24, status=1, ipAttribution=)]
    2016-09-24 刘煜

    学习了谢谢。

    0

相关资讯

CSCO 2016:精彩壁报一览

第十九届全国临床肿瘤学大会暨2016年CSCO学术年会于今日开始在中国·厦门国际会议中心(厦门市思明区环岛东路1693号)隆重召开。如此盛会怎么能少得了小编,下面为大家呈现精彩壁报!、

CSCO 2016:《胰腺癌综合诊治中国专家共识》修订版专家解读

2016年9月21日~9月25日, 目前国内关于胰腺癌的指南有: NCCN胰腺癌临床实践指南中国版(2011) 胰腺癌诊疗规范(2011) 中华医学会胰腺癌诊疗指南(2014) 国外相关指南有: NCCN Guidelines: Pancreatic adenocarcionma (2016 V2) ESMO Clinical Practice Gui

CSCO 2016:用数据讲述中国近十年来肿瘤研究进展(中国VS世界)

导语:2016年9月21日~9月25日,第十九届全国临床肿瘤学大会暨2016年CSCO学术年会在福建厦门隆重召开。汤森路透集团大学和生命科学事业部总经理胡大龙,用数据讲述了中国近十年来肿瘤研究的SCI论文趋势。下面是梅斯医学小编从会场发回来的报道。中国近十年来肿瘤研究的SCI论文趋势:(中国肿瘤研究呈现快速增长,2015年发文量超过35000篇)中美日近10年肿瘤研究趋势:中国近10年肿瘤研究平均

CSCO 2015:全部会议日程(可以下载收藏,手机APP更方便)

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会会议日程(点击下载,或下载MedSci医学APP,然后收藏这篇文章,随时打开查看)17日上午.pdf17日下午.pdf18日上午.pdf18日下午.pdf19日上午.pdf19日下午.pdf卫星会总日程.pdf

CSCO 2016:会议日程与精彩提前知晓

第十八届全国临床肿瘤学大会暨2016年CSCO学术年会会议日程(点击下载,或下载MedSci医学APP,然后收藏这篇文章,随时打开查看)2016 年 09 月 21 日(周三)下午.pdf2016 年 09 月 22 日(周四) 上午.pdf2016 年 09 月 23 日(周五) 上午.pdf2016 年 09 月 24 日(周六) 上午.pdf

CSCO 2015:会议亮点与精彩提前知晓

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会会议日程(点击下载,或下载MedSci医学APP,然后收藏这篇文章,随时打开查看)17日上午.pdf17日下午.pdf18日上午.pdf18日下午.pdf19日上午.pdf19日下午.pdf卫星会总日程.pdf会议亮点提前知晓中国临床肿瘤学会(CSCO)正式成立,成为国家一级学会。今年CSCO 五大特色吴一龙教授:在刚刚过去的8月,中国临床肿瘤